VIA
OLMA icon

Virtus Investment Advisers’s Olema Pharmaceuticals OLMA Stock Holding History

Virtus Investment Advisers’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$415K Buy
33,150
+24,900
+302% +$334K 0.1% 256
2026
Q1 		$123K Buy
8,250
+201
+2% +$4.47K 0.03% 446
2025
Q4 		$201K Sell
8,049
-19,977
-71% -$355K 0.05% 368
2025
Q3 		$274K Buy
28,026
+4,865
+21% +$29.2K 0.08% 242
2025
Q2 		$98.7K Sell
23,161
-1,266
-5% -$5.64K 0.03% 339
2025
Q1 		$91.8K Buy
+24,427
New +$123K 0.03% 432

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Virtus Investment Advisers's OLMA Position: Q2 2026 in Review

Virtus Investment Advisers increased its Olema Pharmaceuticals (OLMA) stake by 302% in Q2 2026, buying an estimated $334K and bringing the position to 33,150 shares worth $415K. The position accounts for 0.1% of the portfolio, ranked #256.

Virtus Investment Advisers first reported a position in OLMA in Q1 2025 and has held it in 6 quarters since. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Virtus Investment Advisers held 33,150 shares of Olema Pharmaceuticals worth $415K as of Q2 2026.
  • Virtus Investment Advisers bought 24,900 Olema Pharmaceuticals shares in Q2 2026, an estimated $334K.
  • Olema Pharmaceuticals made up 0.1% of Virtus Investment Advisers's portfolio in Q2 2026, its #256 holding.
  • Virtus Investment Advisers first reported a position in Olema Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.